Compare $GEHC vs $IDXX | Chartloom

Compare

$GEHC vs $IDXX

GE Healthcare Technologies Inc · IDEXX Laboratories Inc

GEHC

GE Healthcare Technologies Inc

IDXX

IDEXX Laboratories Inc

Compare $GEHC vs $IDXX

Comparing GE Healthcare Technologies Inc and IDEXX Laboratories Inc

GEHCGE Healthcare Technologies Inc

IDXXIDEXX Laboratories Inc

GEHCGE Healthcare Technologies Inc

Market cap

$29.69B

P/E (TTM)

15.04x

Forward P/E (NTM)

12.46x

Forward P/S (NTM)

1.31x

Rev growth (TTM)

6.5%

YTD performance

-20.6%

52W performance

-12.5%

FCF yield

5.3%

IDXXIDEXX Laboratories Inc

Market cap

$40.86B

P/E (TTM)

36.05x

Forward P/E (NTM)

32.49x

Forward P/S (NTM)

8.19x

Rev growth (TTM)

12.8%

YTD performance

-22.7%

52W performance

-17.8%

FCF yield

3.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

GEHC

IDXX

Detailed metrics comparison

GEHC

GE Healthcare Technologies Inc

IDXX

IDEXX Laboratories Inc

Market Cap

GEHC$29.69B

IDXX$40.86B

Enterprise Value

GEHC$37.76B

IDXX$41.63B

Price

GEHC$65.74

IDXX$518.00

P/E Ratio

GEHC15.04x

IDXX36.05x

P/S Ratio

GEHC1.40x

IDXX8.97x

EV/Sales

GEHC1.78x

IDXX9.14x

EV/EBITDA

GEHC11.19x

IDXX25.78x

P/B Ratio

GEHC2.65x

IDXX25.33x

P/FCF Ratio

GEHC18.81x

IDXX33.03x

EV/FCF

GEHC23.92x

IDXX33.65x

PEG Ratio

GEHC2.18x

IDXX2.78x

Forward P/E (NTM)

GEHC12.46x

IDXX32.49x

Forward P/S (NTM)

GEHC1.31x

IDXX8.19x

Revenue (TTM)

GEHC$21.27B

IDXX$4.55B

Revenue Growth (YoY)

GEHC6.5%

IDXX12.8%

Forward Rev Growth

GEHC4.6%

IDXX8.8%

Gross Margin (TTM)

GEHC39.5%

IDXX62.4%

Operating Margin (TTM)

GEHC12.9%

IDXX32.0%

EBITDA Margin (TTM)

GEHC15.7%

IDXX35.4%

Net Margin (TTM)

GEHC9.3%

IDXX25.0%

FCF Margin (TTM)

GEHC7.4%

IDXX27.2%

Net Income (TTM)

GEHC$1.99B

IDXX$1.14B

FCF (TTM)

GEHC$1.58B

IDXX$1.24B

EPS (TTM)

GEHC$4.37

IDXX$14.37

ROE (TTM)

GEHC18.9%

IDXX72.0%

ROA (TTM)

GEHC5.4%

IDXX33.6%

ROIC (TTM)

GEHC9.6%

IDXX45.1%

Cash

GEHC$2.08B

IDXX$197M

Debt

GEHC$10.15B

IDXX$969M

Net Cash/Debt

GEHC$-8.07B

IDXX$-772M

Current Ratio (TTM)

GEHC1.26x

IDXX1.17x

Quick Ratio (TTM)

GEHC0.93x

IDXX0.82x

Debt/Equity (TTM)

GEHC0.92x

IDXX0.60x

Debt/Assets (TTM)

GEHC0.0%

IDXX0.0%

Interest Coverage (TTM)

GEHCN/A

IDXXN/A

Net Debt/EBITDA (TTM)

GEHC0.00x

IDXX0.00x

Beta

GEHC0.85

IDXX1.56

52W Performance

GEHC-12.5%

IDXX-17.8%

YTD Performance

GEHC-20.6%

IDXX-22.7%

% from 52W High

GEHC-26.8%

IDXX-32.7%

% from 52W Low

GEHC11.9%

IDXX3.5%

Asset Turnover (TTM)

GEHC0.58x

IDXX1.34x

FCF Yield (TTM)

GEHC5.3%

IDXX3.0%

Earnings Yield (TTM)

GEHC6.7%

IDXX2.8%

Dividend Yield (TTM)

GEHC0.2%

IDXXN/A

Rule of 40

GEHC13.9

IDXX39.9

EV/GP/RG

GEHC0.71

IDXX1.52

Ticker research

View GEHC research View IDXX research

Metric	GEHC GE Healthcare Technologies Inc	IDXX IDEXX Laboratories Inc
Market & Valuation
Market Cap	$29.69B	$40.86B
Enterprise Value	$37.76B	$41.63B
Price	$65.74	$518.00
P/E Ratio	15.04x	36.05x
P/S Ratio	1.40x	8.97x
EV/Sales	1.78x	9.14x
EV/EBITDA	11.19x	25.78x
P/B Ratio	2.65x	25.33x
P/FCF Ratio	18.81x	33.03x
EV/FCF	23.92x	33.65x
PEG Ratio	2.18x	2.78x
Forward P/E (NTM)	12.46x	32.49x
Forward P/S (NTM)	1.31x	8.19x
Revenue & Growth
Revenue (TTM)	$21.27B	$4.55B
Revenue Growth (YoY)	6.5%	12.8%
Forward Rev Growth	4.6%	8.8%
Profitability
Gross Margin (TTM)	39.5%	62.4%
Operating Margin (TTM)	12.9%	32.0%
EBITDA Margin (TTM)	15.7%	35.4%
Net Margin (TTM)	9.3%	25.0%
FCF Margin (TTM)	7.4%	27.2%
Net Income (TTM)	$1.99B	$1.14B
FCF (TTM)	$1.58B	$1.24B
EPS (TTM)	$4.37	$14.37
ROE (TTM)	18.9%	72.0%
ROA (TTM)	5.4%	33.6%
ROIC (TTM)	9.6%	45.1%
Financial Health
Cash	$2.08B	$197M
Debt	$10.15B	$969M
Net Cash/Debt	$-8.07B	$-772M
Current Ratio (TTM)	1.26x	1.17x
Quick Ratio (TTM)	0.93x	0.82x
Debt/Equity (TTM)	0.92x	0.60x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.85	1.56
52W Performance	-12.5%	-17.8%
YTD Performance	-20.6%	-22.7%
% from 52W High	-26.8%	-32.7%
% from 52W Low	11.9%	3.5%
Efficiency & Yields
Asset Turnover (TTM)	0.58x	1.34x
FCF Yield (TTM)	5.3%	3.0%
Earnings Yield (TTM)	6.7%	2.8%
Dividend Yield (TTM)	0.2%	N/A
Other
Rule of 40	13.9	39.9
EV/GP/RG	0.71	1.52
Ticker research	View GEHC research	View IDXX research

Valuation

P/E Ratio

GEHC

15.04x

IDXX

36.05x

P/S Ratio

GEHC

1.40x

IDXX

8.97x

EV/FCF

GEHC

23.92x

IDXX

33.65x

Growth & revenue

Revenue Growth TTM

IDXX

12.8%

GEHC

6.5%

Forward Revenue Growth

IDXX

8.8%

GEHC

4.6%

Profitability & performance

Gross Margin

IDXX

62.4%

GEHC

39.5%

ROE

IDXX

72.0%

GEHC

18.9%

FCF Yield %

GEHC

5.3%

IDXX

3.0%

52-Week Performance

GEHC

-12.5%

IDXX

-17.8%

Detailed metrics comparison

GEHC

GE Healthcare Technologies Inc

IDXX

IDEXX Laboratories Inc

Market Cap

GEHC$29.69B

IDXX$40.86B

Enterprise Value

GEHC$37.76B

IDXX$41.63B

Price

GEHC$65.74

IDXX$518.00

P/E Ratio

GEHC15.04x

IDXX36.05x

P/S Ratio

GEHC1.40x

IDXX8.97x

EV/Sales

GEHC1.78x

IDXX9.14x

EV/EBITDA

GEHC11.19x

IDXX25.78x

P/B Ratio

GEHC2.65x

IDXX25.33x

P/FCF Ratio

GEHC18.81x

IDXX33.03x

EV/FCF

GEHC23.92x

IDXX33.65x

PEG Ratio

GEHC2.18x

IDXX2.78x

Forward P/E (NTM)

GEHC12.46x

IDXX32.49x

Forward P/S (NTM)

GEHC1.31x

IDXX8.19x

Revenue (TTM)

GEHC$21.27B

IDXX$4.55B

Revenue Growth (YoY)

GEHC6.5%

IDXX12.8%

Forward Rev Growth

GEHC4.6%

IDXX8.8%

Gross Margin (TTM)

GEHC39.5%

IDXX62.4%

Operating Margin (TTM)

GEHC12.9%

IDXX32.0%

EBITDA Margin (TTM)

GEHC15.7%

IDXX35.4%

Net Margin (TTM)

GEHC9.3%

IDXX25.0%

FCF Margin (TTM)

GEHC7.4%

IDXX27.2%

Net Income (TTM)

GEHC$1.99B

IDXX$1.14B

FCF (TTM)

GEHC$1.58B

IDXX$1.24B

EPS (TTM)

GEHC$4.37

IDXX$14.37

ROE (TTM)

GEHC18.9%

IDXX72.0%

ROA (TTM)

GEHC5.4%

IDXX33.6%

ROIC (TTM)

GEHC9.6%

IDXX45.1%

Cash

GEHC$2.08B

IDXX$197M

Debt

GEHC$10.15B

IDXX$969M

Net Cash/Debt

GEHC$-8.07B

IDXX$-772M

Current Ratio (TTM)

GEHC1.26x

IDXX1.17x

Quick Ratio (TTM)

GEHC0.93x

IDXX0.82x

Debt/Equity (TTM)

GEHC0.92x

IDXX0.60x

Debt/Assets (TTM)

GEHC0.0%

IDXX0.0%

Interest Coverage (TTM)

GEHCN/A

IDXXN/A

Net Debt/EBITDA (TTM)

GEHC0.00x

IDXX0.00x

Beta

GEHC0.85

IDXX1.56

52W Performance

GEHC-12.5%

IDXX-17.8%

YTD Performance

GEHC-20.6%

IDXX-22.7%

% from 52W High

GEHC-26.8%

IDXX-32.7%

% from 52W Low

GEHC11.9%

IDXX3.5%

Asset Turnover (TTM)

GEHC0.58x

IDXX1.34x

FCF Yield (TTM)

GEHC5.3%

IDXX3.0%

Earnings Yield (TTM)

GEHC6.7%

IDXX2.8%

Dividend Yield (TTM)

GEHC0.2%

IDXXN/A

Rule of 40

GEHC13.9

IDXX39.9

EV/GP/RG

GEHC0.71

IDXX1.52

Ticker research

View GEHC research View IDXX research

Metric	GEHC GE Healthcare Technologies Inc	IDXX IDEXX Laboratories Inc
Market & Valuation
Market Cap	$29.69B	$40.86B
Enterprise Value	$37.76B	$41.63B
Price	$65.74	$518.00
P/E Ratio	15.04x	36.05x
P/S Ratio	1.40x	8.97x
EV/Sales	1.78x	9.14x
EV/EBITDA	11.19x	25.78x
P/B Ratio	2.65x	25.33x
P/FCF Ratio	18.81x	33.03x
EV/FCF	23.92x	33.65x
PEG Ratio	2.18x	2.78x
Forward P/E (NTM)	12.46x	32.49x
Forward P/S (NTM)	1.31x	8.19x
Revenue & Growth
Revenue (TTM)	$21.27B	$4.55B
Revenue Growth (YoY)	6.5%	12.8%
Forward Rev Growth	4.6%	8.8%
Profitability
Gross Margin (TTM)	39.5%	62.4%
Operating Margin (TTM)	12.9%	32.0%
EBITDA Margin (TTM)	15.7%	35.4%
Net Margin (TTM)	9.3%	25.0%
FCF Margin (TTM)	7.4%	27.2%
Net Income (TTM)	$1.99B	$1.14B
FCF (TTM)	$1.58B	$1.24B
EPS (TTM)	$4.37	$14.37
ROE (TTM)	18.9%	72.0%
ROA (TTM)	5.4%	33.6%
ROIC (TTM)	9.6%	45.1%
Financial Health
Cash	$2.08B	$197M
Debt	$10.15B	$969M
Net Cash/Debt	$-8.07B	$-772M
Current Ratio (TTM)	1.26x	1.17x
Quick Ratio (TTM)	0.93x	0.82x
Debt/Equity (TTM)	0.92x	0.60x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.85	1.56
52W Performance	-12.5%	-17.8%
YTD Performance	-20.6%	-22.7%
% from 52W High	-26.8%	-32.7%
% from 52W Low	11.9%	3.5%
Efficiency & Yields
Asset Turnover (TTM)	0.58x	1.34x
FCF Yield (TTM)	5.3%	3.0%
Earnings Yield (TTM)	6.7%	2.8%
Dividend Yield (TTM)	0.2%	N/A
Other
Rule of 40	13.9	39.9
EV/GP/RG	0.71	1.52
Ticker research	View GEHC research	View IDXX research